183490.KQ

Enzychem Lifesciences Corporation [183490.KQ] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

183490.KQ Stock Summary

Top 10 Correlated ETFs

183490.KQ


Top 10 Correlated Stocks

183490.KQ


In the News

183490.KQ Financial details

Company Rating
Neutral
Market Cap
169.28B
Income
-9.33B
Revenue
76.04B
Book val./share
2274.9
Cash/share
1613.18
Dividend
-
Dividend %
-
Employees
113
Optionable
No
Shortable
Yes
Earnings
13 May 2024
P/E
-8.08
Forward P/E
-
PEG
1.23
P/S
3.26
P/B
0.75
P/C
1.16
P/FCF
-9.14
Quick Ratio
14.47
Current Ratio
16.04
Debt / Equity
0.03
LT Debt / Equity
0.01
-
-
EPS (TTM)
-109.82
EPS next Y
-
EPS next Q
-
EPS this Y
-65.51%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-17.33%
Revenue last 5Y
19.3%
Revenue Q/Q
17.43%
EPS Q/Q
-30.45%
-
-
-
-
SMA20
16.08%
SMA50
10.62%
SMA100
59.17%
Inst Own
-
Inst Trans
-
ROA
-9%
ROE
-9%
ROC
-0.07%
Gross Margin
8%
Oper. Margin
-30%
Profit Margin
-40%
Payout
-
Shs Outstand
85.07M
Shs Float
69.97M
-
-
-
-
Target Price
-
52W Range
1110.0-2290.0
52W High
-17.99%
52W Low
+69.19%
RSI
58.49
Rel Volume
1.23
Avg Volume
278.78K
Volume
342.85K
Perf Week
-0.21%
Perf Month
7.5%
Perf Quarter
30.96%
Perf Half Y
29.25%
-
-
-
-
Beta
1.449
-
-
Volatility
57.74%, 137.43%
Prev Close
-0.21%
Price
1878
Change
-4.96%

183490.KQ Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2023-12-31

Metric History 2019-12-312020-12-312021-12-312022-12-31 2023-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
530.05420.05460.48337.96895.32
Net income per share
-284.31-284.83-558.47-318.36-109.81
Operating cash flow per share
-254.26-228.11-372.56-181.68-120.78
Free cash flow per share
-302.13-278.49-490.46-283.34-147.89
Cash per share
765.061.47K1.9K2.45K1.62K
Book value per share
1.25K1.18K1.5K2.56K2.28K
Tangible book value per share
1.22K1.15K1.37K2.53K2.27K
Share holders equity per share
1.25K1.18K1.5K2.56K2.28K
Interest debt per share
49.69719.361.23K600.167.03
Market cap
2701.31B2796.65B2270.2B131.63B153.04B
Enterprise value
2702.12B2837.86B2319.4B161.73B143.23B
P/E ratio
-160.04-159.75-81.47-5.25-16.41
Price to sales ratio
85.84108.3298.814.942.01
POCF ratio
-178.95-199.46-122.13-9.19-14.92
PFCF ratio
-150.6-163.38-92.77-5.89-12.18
P/B Ratio
36.4838.5830.410.650.79
PTB ratio
36.4838.5830.410.650.79
EV to sales
85.87109.92100.956.071.88
Enterprise value over EBITDA
-186.92-179.68-124.41-13.03-12.76
EV to operating cash flow
-179-202.4-124.77-11.29-13.96
EV to free cash flow
-150.64-165.79-94.78-7.24-11.4
Earnings yield
-0.01-0.01-0.01-0.19-0.06
Free cash flow yield
-0.01-0.01-0.01-0.17-0.08
Debt to equity
0.040.590.690.180.03
Debt to assets
0.030.350.390.150.02
Net debt to EBITDA
-0.06-2.61-2.64-2.420.87
Current ratio
8.4310.732.055.2112.33
Interest coverage
-103.64-12.16-2.18-1.48-23.76
Income quality
0.890.80.670.571.1
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
0.160.210.350.260
Research and developement to revenue
0.360.50.410.250.07
Intangibles to total assets
0.020.020.050.010.01
Capex to operating cash flow
0.190.220.320.560.22
Capex to revenue
-0.09-0.12-0.26-0.3-0.03
Capex to depreciation
-1.46-1.52-2.79-3.35-0.66
Stock based compensation to revenue
00000
Graham number
2.82K2.75K4.34K4.28K2.37K
ROIC
-0.22-0.14-0.15-0.06-0.07
Return on tangible assets
-0.2-0.14-0.22-0.1-0.04
Graham Net
767.04771900.352.03K1.69K
Working capital
55.74B95.21B56.16B178.03B160.32B
Tangible asset value
72.48B70.51B68.19B199.56B193.15B
Net current asset value
52.29B53.68B51.36B174.5B157.56B
Invested capital
0.040.590.690.180.03
Average receivables
8.55B7.1B5.39B8.31B15.94B
Average payables
1.86B1.8B1.56B1.87B3.99B
Average inventory
7.49B8.51B8.77B9.07B12.37B
Days sales outstanding
110.566.1297.02144.01102.54
Days payables outstanding
34.0512.9335.1721.8332.58
Days of inventory on hand
97.6136.76130.59142.8974.99
Receivables turnover
3.35.523.762.533.56
Payables turnover
10.7228.2310.3816.7211.2
Inventory turnover
3.742.672.792.554.87
ROE
-0.23-0.24-0.37-0.12-0.05
Capex per share
-47.87-50.38-117.9-101.66-27.11

Quarterly Fundamentals Overview

Last date of statement is 2023-12-31 for Q4

Metric History 2022-12-312023-03-312023-06-302023-09-30 2023-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
78.87184.98204.88232.36272.86
Net income per share
-102.73-28.46-28.85-30.97-21.54
Operating cash flow per share
-48.29-21.1-45.55-30.13-23.95
Free cash flow per share
-69.2-30.3-46.83-40.38-30.34
Cash per share
2.29K1.89K1.78K1.71K1.61K
Book value per share
2.39K2.36K2.32K2.28K2.27K
Tangible book value per share
2.37K2.29K2.26K2.21K2.27K
Share holders equity per share
2.39K2.36K2.32K2.28K2.27K
Interest debt per share
456.22111.6667.2264.8560.46
Market cap
140.76B161.84B157.8B128.02B153.29B
Enterprise value
170.86B167.99B155.88B129.44B143.47B
P/E ratio
-4.06-16.82-16.07-12.15-20.91
Price to sales ratio
21.1810.359.056.486.6
POCF ratio
-34.58-90.78-40.73-49.95-75.23
PFCF ratio
-24.13-63.21-39.61-37.27-59.4
P/B Ratio
0.70.810.80.660.79
PTB ratio
0.70.810.80.660.79
EV to sales
25.710.758.946.556.18
Enterprise value over EBITDA
-58.22-75.38-54.26-38.81-51.49
EV to operating cash flow
-41.98-94.23-40.23-50.5-70.41
EV to free cash flow
-29.29-65.61-39.13-37.68-55.6
Earnings yield
-0.06-0.01-0.02-0.02-0.01
Free cash flow yield
-0.04-0.02-0.03-0.03-0.02
Debt to equity
0.180.050.030.030.03
Debt to assets
0.150.040.030.030.02
Net debt to EBITDA
-10.26-2.760.67-0.433.52
Current ratio
5.2111.3216.0411.712.33
Interest coverage
-3.03-7.46-50.56-65.81-51.24
Income quality
0.470.741.580.971.11
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
0.30.130.1300
Research and developement to revenue
0.210.110.080.050.06
Intangibles to total assets
0.010.030.030.030.01
Capex to operating cash flow
0.430.440.030.340.27
Capex to revenue
-0.27-0.05-0.01-0.04-0.02
Capex to depreciation
-2.71-0.94-0.11-0.96-0.66
Stock based compensation to revenue
00000
Graham number
2.35K1.23K1.23K1.26K1.05K
ROIC
-0.02-0.01-0.02-0.02-0.01
Return on tangible assets
-0.04-0.01-0.01-0.01-0.01
Graham Net
1.9K1.81K1.77K1.71K1.69K
Working capital
178.03B167.96B166.5B164.03B160.32B
Tangible asset value
199.56B193.52B192.04B188.06B193.15B
Net current asset value
174.5B164.35B161.35B158.55B157.56B
Invested capital
0.180.050.030.030.03
Average receivables
9B10.06B10.46B14.9B19.92B
Average payables
1.94B2.43B3.16B4.97B6.75B
Average inventory
9.86B11.21B13.19B14.09B14.67B
Days sales outstanding
142.355.2758.584.182.83
Days payables outstanding
22.6420.9415.7732.7226.29
Days of inventory on hand
148.2478.3773.8567.3460.52
Receivables turnover
0.631.631.541.071.09
Payables turnover
3.974.35.712.753.42
Inventory turnover
0.611.151.221.341.49
ROE
-0.04-0.01-0.01-0.01-0.01
Capex per share
-20.91-9.2-1.29-10.25-6.38

183490.KQ Frequently Asked Questions

What is Enzychem Lifesciences Corporation stock symbol ?

Enzychem Lifesciences Corporation is a KR stock and trading under the symbol 183490.KQ

What is Enzychem Lifesciences Corporation stock quote today ?

Enzychem Lifesciences Corporation stock price is $1878 today.

Is Enzychem Lifesciences Corporation stock public?

Yes, Enzychem Lifesciences Corporation is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated ETFs
Top Correlated Stocks
Similar Market Cap